OBJECTIVES: The objective of this research is to provide an overview of the regulatory process of drug delivery in social networks and the impact on healthcare in Russia. This analysis was carried out to evaluate the availability and reliability of innovation methods (drug delivery by social networks) in Russian healthcare. METHODS: Studies were retrieved from relevant regulatory authorities’ databases (Roszdravnadzor, AIS Roszdavnadzor and Ministry of Health of the Russian Federation web portals), using relevant search strategies. Included studies were primarily conducted in various healthcare settings in Russia. The search methodology employed was in line with AIS guidelines. The search language was limited to Russian. RESULTS: In total, 50 records were included in the qualitative synthesis of this review. The governance, process and implementation of drug market access have been analyzed in detail. The successful implementation of drugs delivery was primarily used in cities. Further use included identification of knowledge dissemination of drugs delivery by networks in villages and small cities. Challenges are related to the interim nature of  legislation. In addition there is a lack of transparency and electronic databases. Detailed analyses of the findings from studies are still ongoing. CONCLUSIONS: Preliminary analysis shows that limited evidence exists on the impact of innovatiom methods on healthcare in Russia. In Russia drugs delivery by social network access is straightforward if there is proof of authorization to sell a product and licenses. It also highlights the disparity in the awareness among people regarding the utility of drug delivery by social networks. For a country with divergent health systems and a huge rural population, the use drug delivery by social networks may be very impactful in improving healthcare. However, this system has disadvantages in terms of safeguarding patient safety. Lack of transparency, incomplete regulations are challenges faced by Russia.